Emyria Limited (ASX:EMD)
Australia · Delayed Price · Currency is AUD 0.0470
-0.0010 (-2.08%)
Jul 29, 2026, 3:22 PM AEST
Emyria Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 2.29 | 1.39 | 2.2 | 1.59 | 1.82 | 1.98 |
Revenue Growth | 64.26% | -36.68% | 38.32% | -12.62% | -7.77% | 94.97% |
Gross Profit Gross Profit Growth | 0.46 | 0.02 | -0.17 | -0.65 | -0.53 | -0.3 |
Operating Income Operating Income Growth | -3.87 | -2.49 | -3.33 | -4.24 | -6.85 | -3.43 |
Net Income Net Income Growth | -4.55 | -3.14 | -11.46 | -5.13 | -7.33 | -4.91 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.03 | -0.02 | -0.03 | -0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Clinical Services Mind Body Consulting (Pax Centre) Clinical Services Mind Body Consulting (Pax Centre) Growth | 0.75 | 0.66 | - | - | - | - |
Clinical Services Other Clinical Services Other Growth | 1.45 | 0.65 | - | - | - | - |
Corporate Services Corporate Services Growth | - | 0.09 | - | - | - | - |
Health Care Technology and Clinical Research Company Health Care Technology and Clinical Research Company Growth | - | - | 2.2 | 1.59 | 1.82 | 1.98 |
Total Total Growth | 2.29 | 1.39 | 2.2 | 1.59 | 1.82 | 1.98 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 10.5 | 3.57 | 1.57 | 2.73 | 3.88 | 6.53 |
Total Debt Total Debt Growth | 0.56 | 0.61 | 1.72 | 1.27 | 0.63 | 0.95 |
Net Cash (Debt) Net Cash Growth | 9.95 | 2.96 | -0.15 | 1.46 | 3.25 | 5.58 |
Net Cash Growth | 236.38% | - | - | -54.96% | -41.81% | 81.41% |
Net Cash Per Share Net Cash Per Share Growth | 0.02 | 0.01 | -0.00 | 0.01 | 0.01 | 0.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.72 | -2.7 | -4.28 | -3.77 | -5.43 | -3.94 |
Capital Expenditures CapEx Growth | -0.06 | -0.01 | -0.16 | -0.02 | -0.05 | -0.01 |
Free Cash Flow Free Cash Flow Growth | -3.77 | -2.72 | -4.44 | -3.79 | -5.48 | -3.95 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 20.15% | 1.76% | -7.61% | -40.66% | -28.82% | -15.19% |
Operating Margin | -169.05% | -178.80% | -151.22% | -266.46% | -375.89% | -173.48% |
Pretax Margin | -198.54% | -225.33% | -520.07% | -322.21% | -402.09% | -248.30% |
Profit Margin | -198.54% | -225.33% | -520.07% | -322.21% | -402.09% | -248.30% |
FCF Margin | -164.72% | -194.91% | -201.75% | -237.89% | -300.74% | -199.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PS Ratio | 16.55 | 12.28 | 7.61 | 24.20 | 28.67 | 23.79 |